Medications

FDA advisers back full approval of Paxlovid

Paxlovid, a medication that has helped millions of high-risk COVID-19 patients avoid hospitalization and death since late 2021, moved one step closer to getting full approval from the U.S. Food and Drug Administration on ...

Diseases, Conditions, Syndromes

Researchers find immune response to COVID strengthens over time

Immunity from COVID-19 appears to gather strength with more time between vaccination and infection, a new laboratory study from researchers at Oregon Health & Science University suggests. The findings carry implications for ...

page 2 from 11